ロード中...
Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells
Abnormal histone deacetylase (HDAC) expression is closely related to cancer development and progression. Many HDAC inhibitors have been widely used in cancer treatment; however, severe side effects often limit their clinical application. In this study, we attempted to identify natural compounds with...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7052045/ https://ncbi.nlm.nih.gov/pubmed/32158695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00216 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|